Login / Signup

Nanoencapsulation of Maqui ( Aristotelia chilensis ) Extract in Chitosan-Tripolyphosphate and Chenopodin-Based Systems.

Daniela AndradeFrancisca Maldonado-BravoAmador AlburquerqueCamilo PérezAlexander GamboaNelson CaroMario Díaz-DosqueMartin GottelandLilian AbugochCristian Tapia
Published in: Antioxidants (Basel, Switzerland) (2024)
Maqui berries contain a high percentage of anthocyanins with high antioxidant and anti-inflammatory capacity but that are unstable in the colonic site. Nanocarriers based on polysaccharides and/or proteins can protect against the degradation of anthocyanins. The aim of this study was the nanoencapsulation of maqui extract (ME) in chitosan-tripolyphosphate (CTPP-ME), chenopodin (CH-ME), and chenopodin-alginate (CHA-ME). A standardised ME was prepared and then encapsulated in the nanosystems. The physicochemical properties, encapsulation parameters, and the interactions of ME with the nanovehicles were characterised. The cyanidin-3-glucoside released and ORAC activity in phosphate buffer at pH 7.4 were evaluated. The content of ME was 8-9 mg of cyanidin-3-glucoside/g of extract. CTPP with ME at 3% obtained the highest encapsulation efficiency (EE = 91%), and no significant differences were observed in size (274-362 nm), PDI (0.5-0.7), and zeta potential (+34-+41 mV) when the concentration of ME changed from 1% to 5%. CH-ME was shown to be smaller (152 nm) than CTPP-ME, and CH-ME and CHA-ME showed lower EE (79% and 54%, respectively) than CTPP-ME. FT-IR revealed a stronger interaction of ME with CTPP-ME than with CH-ME. Both systems showed a significantly lower release than free ME, and the T50 value of CTPP-ME 3% (328 min) was higher than CH-ME (197 min). Both protected the ORAC activity of ME.
Keyphrases
  • anti inflammatory
  • room temperature
  • drug delivery
  • oxidative stress
  • photodynamic therapy
  • risk assessment
  • ionic liquid
  • drug release
  • human health